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Purpose: The use of tissue expander/implant in breast
reconstruction using tissue expander-implant is one of the
most common surgical procedures. The use of AlloDerm
as a sling to reestablish the lower pole of the pectoralis
major muscle results a decrease in morbidity compared
with more invasive procedures. However the use of
AlloDerm is more expensive than other options. We
decided to compare AlloDerm with Permacol, which has
been safely used in human body reconstruction and is less
costly than AlloDerm.
Methods: After mastectomy, the inferolateral origin of
the pectoralis major muscle was elevated. Either AlloDerm
or Permacol was sutured to the chest wall at the level of the
previously marked inframammary fold. The lower border of
the pectoralis major muscle and the upper portion of the
crescent-shaped piece of either AlloDerm or Permacol was
sutured together using a tension free technique, and a
tissue expander was subsequently inserted into the
subpectoral-subAlloDerm (or Permacol) dual pocket.
Results:AlloDerm was used in twenty-one patients (28
breasts) and Permacol was used in six patients (11
breasts) for tissue expander-implant breast reconstruction.
During the mean follow-up period of 17 months (8~25
months). Two infections (7%) occurred in AlloDerm cases
and four infections (36%) occurred in Permacol cases.
Conclusion:This study is the first comparison of tissue
expander/implant breast reconstruction using AlloDerm
and Permacol. The use of Permacol resulted in more post-
operative infection compared with the use of AlloDerm.
This report is still limited with the small number of cases
studied.
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I. INTRODUCTION
There are two principle methods of breast reconstruc-
tion following mastectomy for the treatment of breast
cancer: the use of autologous tissue or prosthetic devices.
Implant-based breast reconstruction methods have been
subject of many studies. A autologous breast reconstruc-
tion is the most frequently used method. The tissue
expander/implant method requires the insertion of a
tissue expander after mastectomy, subsequent gradual
saline injection expanding the surrounding tissues, and
substitution with permanent implants after several
weeks. This method has a number of advantages over
autologous tissue reconstruction in that it results in
texture, color and sensation similar to that of the adjacent
tissue, shorter operation time, minimal scarring, faster
recovery, and avoidance of donor site morbidity.1 Tissue
expanders are inserted under the pectoralis major muscle
by lifting the inferiolateral portion of the muscle. However,
complete coverage of the expanders by the muscle is
often difficult to achieve. This could result in a number
of complications, including capsular contracture and
expander/implant exposure or extrusion. Having a
portion of the expander/implant covered only by a
skin-subcutaneous tissue flap, and not by muscle, leads
to thinning of the soft tissues of the inferior pole of the
breast.1,2 In order to prevent this side effect, a method
for creating inducing a complete submuscular pocket by
elevating both the pectoralis major and the anterior
serratus muscle was developed. However, this method
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could lead to malpositioning of the implants above the
inframammary fold.2 In 2005, Breuning et al. developed
the AlloDerm-Sling technique in which they created a
subpectoral-subAlloDerm pocket using AlloDerm of
0.79~1.78mm thickness, which was originally developed
for breast reconstruction since 2004, and firmly secured
in the position of the inframammary fold. This technique
is performed in order to reduce thinning of soft tissues
after tissue expansion and to achieve satisfactory lower-
pole fullness.1 Subsequent studies by Gamboa-Bobadilla,
Salzberg, Bindingnavele and others have also docu-
mented aesthetically satisfying results using AlloDerm
in breast reconstruction.3-5 In addition, Preminger et al.
no difference in the rate of postoperative complications
such as seroma (6.7%), hematoma (6.7%), infection (2.2%)
between AlloDerm-sling technique and older methods
using tissue expanders and implants.6 Although this
method is safe and result in excellent outcomes, AlloDerm-
sling technique has its limitations of raising the cost of
treatment 33%.
Permacol , developed in the United Kingdom in 1998,
is an acellular dermis extracted from porcine skin, made
to resist biodegradation by removing cellular and
noncollagenous debris.7 Permacol has been reported to
be safe when applied to various parts of the body and
to have similar efficacy of AlloDerm in abdominal wall
reconstruction.8,9 The goal of this study was to compare
the efficacy and safety of Permacol , which is 50% less
expensive than AlloDerm , with that of a similar
thickness of AlloDerm , in tissue expander/implant
breast reconstruction.
. MATERIALS AND METHODSⅡ
A. Subject
Patients who underwent total mastectomy due to breast
cancer at Gangnam Severance Hospital from January
2008 to June 2010 were included in this retrospective
study. A total of 27 patients underwent surgery; 21 with
AlloDerm (LifeCell Corporation, Woodlands, TX) and
6 with Permacol (Tissue Science Laboratories, Inc.,
Andover, MA). Thirty-nine breasts were studied; 28 cases
of AlloDerm and 11 cases of Permacol (Table I). Mean
age, mean BMI, mean duration of follow up, mean size
of tissue expanders (cc), and mean volume of tissue
expansion were recorded. AlloDerm , with an average
thickness of 0.71~1.66mm, and Permacol , with an aver-
age thickness of 1.5 mm, were used. Tissue expanders
(textured, contour profile; Mentor Co. U.S.A) with an
insertion port on the anterior surface were used in all
patients. Postoperative complications including infection,
hematoma, seroma, and implant exposure were compared
between the two groups. AlloDerm and Permacol
were sampled on 7 days after operation to compare
collagen structure (Masson’s trichrome stain), cellular
infiltration (hematoxylin and eosin stain), and neovas-
cularization (CD31 immuno stain). AlloDerm sample
was obtained from the patient without infection by
lateral small incision on the local anesthesia. Permacol
sample was obtained from the patient who had
symptoms of infection sign when the wound irrigation
with saline. All samples obtained after receiving informed
consent.
B. Operation method
The pectoralis major muscle was approached through
the incision and the muscle origin was elevated from the
chest wall. Previously measured tissue expanders were
inserted under the pectoralis major muscle and either
AlloDerm or Permacol was trimmed to an appropriate
size in order to match the area of expander not covered
by the muscle. Using #3 absorbable suture material
(Polysorb, United States Surgical Corp.), the prepared
material was continually sutured to the inferior border
of the dissected pectoralis major muscle superiorly, the
superior border of the serratus anterior muscle laterally,
and to the chest wall on the same level as the contrala-
teral inframammary fold inferiorly. The patient was
positioned to sit up at 90 degree angle in order to ensure
symmetry with the contralateral inframammary fold and
to appropriately adjust the position of the AlloDerm
or Permacol before anchoring it. Subsequently, an
appropriate amount of saline that would not exert
tension on the skin flaps was injected into the tissue
expanders in order to prevent translocation and compli-
cations including seroma. One drain was placed and
antibiotics were used for 7 to 10 days after the operation
in order to prevent postoperative infection. Tissue
expansion by saline injection began from the 10 to 14
days after operation, and tissue expanders were replaced
with permanent implants six months later.
C. Statistical Analysis
SPSS (version 18.0) was used for statistical analysis,
and all mean values were presented as mean ± standard
deviation. The Kolmogrov-Smirnov test was used for
normality test of all variables of the two groups. In order
to check out that there is no difference between the
subjects of the AlloDerm and the Permacol groups,
pairwise comparisons were performed using the inde
Table I. Summary of Patients
Case
Age
(Year)
Follow up
(Month)
Diagnosis
BMI
(kg/m
2
)
Material
(size: cm/Thickness: mm)
T/E
(cc)
Total inflation(cc) Site Timing
1 28 25 DCIS 18.83 A 5*15/ 0.0.53-0.76 350 320 U I
2 35 25 DCIS 22.5 A 5*13/0.53-0.76 300 400 U I
3 44 22 DCIS 22.24 A 8*15/0.53-0.76 350 300 U I
4 44 20 DEH 20.57 A 5*13/0.53-0.76 350 260 U D
5 59 18 IDC 24.3 A 4*19/0.53-0.76 450 210 U I
6 54 19 Lt.: CCH
Rt.: DCIS
25.18 A 8*15/0.53-0.76 350 390 B I
7 42 16 DCIS 21.83 A 6*11/0.53-0.76 450 400 U I
8 25 16 IDC 18.08 A 4*16/0.79-2.03 350 380 U I
9 41 20 Lt.: FAH
Rt.: DCIS
19.03 A 4*16/0.79-2.03 350 355 B I
10 39 12 DCIS 21.17 A 4*16/0.79-2.03 350 350 B I
11 36 19 DCIS 17.3 A 4*16/0.79-2.03 350 100 U I
12 40 22
Lt.: DCIS
Rt.: FD
16.89 A 4*16/0.79-2.03 350 280 B I
13 37 13 IDC 24.36 A 4*16/0.79-2.03 550 520 U I
14 44 8 Lt.: DCIS
Rt.: ADH
22.27 A Lt.: 4*12/0.79-2.03
Rt.: 4*16/0.79-2.03
350 390 B I
15 35 13 Lt.: ILC
Rt.: ADH
17.09 A Lt.: 4*12/0.79-2.03
Rt.: 4*16/0.79-2.03
350 270 B D
16 32 10 IDC 18.81 A 4*16/0.79-2.03 350 310 U I
17 37 25 PT 22.15 A 4*16/0.79-2.03 450 480 U I
18 46 15 TC 25.39 A 4*16/0.79-2.03 450 420 U I
19 32 12 FD 20.83 A 4*16/0.79-2.03 450 430 U D
20 31 20 IDC' 22.64 A 8*14/0.79-2.03 450 430 U I
21 36 21 IDC 22.04 A Lt.: 4*16/0.79-2.03
Rt.: 4*12/0.79-2.03
Lt: 350
Rt.:450
Lt.:450
Rt.:380
B Lt.: I
Rt.: D
22 35 18 DCIS 19.33 P 10*15/1.5 350 380 U I
23 33 12 DCIS 21.05 P 10*15/1.5 350 360 B I
24 45 17 Lt.: IP
Rt.: DCIS
20.83 P 10*15/1.5 350 330 B I
25 38 15 Lt.: DCIS
Rt.: FAH
22.83 P 10*15/1.5 350 380 B I
26 34 17 DCIS 19.04 P 10*15/1.5 350 355 B I
27 48 19 IP 22.97 P 5*7.5/1.5 450 Lt.:380
Rt.:375
B I
DCIS, Ductal carcinoma in situ; DEH, Ductal epithelial hyperplasia; IDC, Invasive ductal carcinoma; CCH, Columnar cell hyperplasia;
FAH, Fibroadeomatoid hyperplasia; FD, Fibrocystic disease; ADH, Atypical ductal hyperplasia; ILC, Invasive lobular carcinoma; PT,
Phyllodes tumor; TC, Tubular carcinoma; IDC, Infiltrating ductal carcinoma; IP, Intraductal papilloma; A, AlloDerm; P, Permacol;
T/E, Tissue expander; U, Unilateral; B, Bilateral; I, Immediate; D, Delayed.
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pendent T-test for continuous variables. For compare of
the complications of the AlloDerm and the Permacol
groups, the Chi-square test was used for categorical
variables. And a p-value less than 0.005 was defined as
statistically significant.
III. RESULTS
A mean age of 39.5 (± 7.78) years, average follow up
period of 17.6 (± 5.01) months, average BMI of 20.9 (±
2.73) kg/m2, average tissue expander size of 381.5 (± 57.4)
cc and average volume of expansion of 352.2 (± 88.7) cc
were noted in the AlloDerm group. For the Permacol
group, an average age of 40.4 (± 6.06) years, average
follow-up period of 16.6 (± 2.21) months, average BMI of
21.4 (± 1.56) kg/m2, average tissue expander size of 372.2
(± 44.1) cc and average volume of expansion of 363.3 (±
21.2) cc were recorded. So significant differences between
the two groups in these parameters were not detected,
except for the mean follow up period (Table II).
In the AlloDerm group, there were five cases (17%)
of postoperative complications; two cases of infection
(7%), one case of hematoma (2.7%), one case of seroma
(3.7%), one case of implant exposure (3.7%), among which
infection and implant exposure occurred concurrently in
one breast. In the infected case, breast reconstruction was
completed by irrigating the subpectoral-sub-AlloDerm
pocket with saline, replacing the infected tissue expander
with a new expander and continuing expansion. In the
Permacol group, there were five cases in which compli-
cations including four cases of infection (36%), one case
of seroma (9%) and one case of implant exposure (9%).
One case of seroma and infection occurred in one breast,
and one case of implant exposure and infection occured
in one breast (Table III). Significant differences were
detected between the two groups in infection occurrence
(p=0.02) and total complication occurrence (p=0.01). One
case of infection was treated with antibiotics and normal
saline irrigation alone, while two cases required replace-
ment of infected tissue expanders to complete breast
reconstruction.
Histologic comparison of samples collected on the
seventh postoperative day revealed thicker, coarser
collagen fiber structures in the Permacol group (Fig. 1)
Table II. Matching with AlloDerm and Permacol
Total (n = 39) AlloDerm (n = 28) Permacol (n = 11) p-value
Mean Age (Year) 39.8 (± 7.32) 39.5 (± 7.78) 40.4 (± 6.06) 0.78
Mean Follow up (Month) 17.3 (± 4.48) 17.6 (± 5.01) 16.6 (± 2.21) 0.008
Mean BMI (kg/m2) 21.1 (± 2.48) 20.9 (± 2.73) 21.4 (± 1.56) 0.53
Mean tissue expander size (cc) 379.17 (± 53.95) 381.48 (± 57.42) 372.2 (± 44.09) 0.45
Mean volume of inflation(cc) 355 (± 77.23) 352.22 (± 88.67) 363.3 (± 21.06) 0.80
Values are mean ± standard deviation.
The independent T-test was used for statistical analysis.
*: p-value > 0.05
: p-value < 0.05
Table III. Complications after AlloDerm and Permacol
AlloDerm (n = 29) Permacol (n = 11) p-value
Infection 2 (7%) 4 (36%) 0.02
Hematoma 1 (3.7%) 0 (0%) > 0.99
Seroma 1 (3.7%) 1 (9%) > 0.99
Implant exposure 1 (3.7%) 1 (9%) > 0.99
Total 5 (17.2%) 6 (54.5%) 0.01
The Chi-square test was used for statistical analysis.
*: p-value > 0.05
: p-value < 0.05
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analysis of Masson’s trichrome staining. Cellular infiltra-
tion on hematoxylin and eosin staining (Fig. 2) and
endothelial cell prolifereation evidenced by CD31 immu-
nostaining (Fig. 3) appeared only the AlloDerm group.
Case 1
A 47 year old female was admitted for bilateral breast cancer.
After bilateral total mastectomy, a subpectoral- subPermacol
pocket was created using a 1.5-mm-thick, 10 × 15 cm
2
piece
of Permacol , 350 cc tissue expanders were inserted, and 130
Fig. 1. Histologic analysis demonstrated more thick and coarse collagen fiber in Permacol (Right) than AlloDerm (Left) 1 week
after operation (Masson’s trichrome, × 100).
Fig. 2. Histologic analysis demonstrated more cell infiltration (arrow) in AlloDerm (Left) than Permacol (Right) 1 week after
operation (H & E, × 100).
Fig. 3. Histologic analysis demonstrated more endothelial cell ingrowth (arrow) in AlloDerm (Left) than Permacol (Right) 1
week after operation (CD31, × 100).
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cc of saline was subsequently injected. A microbial culture
study at the time of drain removal on the right breast revealed
Pseudomonas aeruginosa. Infection was controlled with anti-
biotics and saline irrigation and tissue expansion was continued
without replacement of tissue expanders. Since subsequent
culture studies during tissue expansion were negative for
microbial growth and there were no clinical symptoms of
mastitis, tissue expanders filled to 330 cc were replaced with
220 cc cohesive-gel prosthetic breast implants (Fig. 4).
Case 2
A 50-year-old female was admitted for bilateral breast
cancer. After bilateral total mastectomy, a subpectoral-sub-
Permacol pocket was created using a 1.5-mm-thick, 5 × 7.5
cm
2
piece of Permacol , 450 cc tissue expanders were inserted,
and 200 cc of saline was subsequently injected. Symptoms of
mastitis manifested in the right breast, which was treated
with antibiotics and saline irrigation. Later, exudate appeared
at the incision site on the left breast, which was treated with
antibiotics, saline irrigation, and tissue expander replacement.
As there was no subsequent mastitis and tissue expansion
was safely completed, tissue expanders were replaced with
cohesive-gel prosthetic breast implants (Fig. 5).
IV. DISCUSSION
Two-stage breast reconstruction using tissue expander/
Fig. 4. (Left) Preoperative view. (Right) One year after tissue expander removal and change with smooth cohesive gel
mammary implant.
Fig. 5. (Left) Preoperative view. (Center) Three month after tissue expander insertion. (Right) Three month after tissue
expander removal and change with smooth cohesive gel mammary Implant.
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implants is a frequently used method of bilateral recon-
struction as there is no loss of donor site tissue. Compli-
cations such as implant exposure, capsular contracture
and extrusion of the tissue expander due to skin necrosis
are generally prevented by completely enclosing the tissue
expanders within the submuscular pocket.10 However,
even if complete coverage is possible, the possibility of
side effects due to the high riding of the implant over
the inframammary fold still remains.4 In order to address
tgus complication, Breuing et al. developed tissue ex-
pander/implant breast reconstruction method using
AlloDerm instead of the anterior serratus muscle to
cover up the inferior portion of the tissue expanders,
which provides support to the soft tissues in the lower
pole of the breast.
1 This technique reduces complications
including both implant exposure or extrusion, and
capsular contracture and upward deviation of the
implants.1 Preminger6 et al. reported that tissue expander/
implant breast reconstruction using AlloDerm does not
increase the risk of postoperative complications compared
with conventional methods. Yoon JH et al.9 reported
similar results when the AlloDerm sling operation was
used Asian women. Despite its efficacy and safety, a
significant amount of AlloDerm is needed to cover up
the inferior portion of the tissue expanders, thereby
raising operation costs by 33%. For this reason, this study
examined the use of Permicol as a dermal substitute,
Permicol is 50% less expensive than AlloDerm and has
been used safely in reconstructive surgery.
Permicol is an acellular dermis extracted from
porcine skin from which cellular and noncollagenous
debris known to cause immunologic reactions, have been
removed.7 Animal studies have shown that the use of
permacol does not lead to allergic reaction, cytotoxicity,
mutation induction capability, systemic reaction, or intra-
dermal reaction. Permicol has attained CE (Conformite
Europea) Mark Class III and can be safely used in all
parts of the human body. Its use in abdominal wall
reconstruction has been approved by the United States
FDA. Permacol transplanted on the abdominal wall
maintains its innate strength while inducing the growth
of surrounding fibroblasts and neovascularization,
eventually leading to permanent integration into the
patient’s tissue.8 Permacol is mostly composed of type
I collagen (93~95%) and small amount of elastin and type
III collagen, and its chemically assembled three dimen-
sional structure renders it resistant to biodegradation as
opposed to AlloDerm which has non cross-linked
collagen structure.11 Patrick et al published that Permacol
can be a reasonable alternative to AlloDerm in that
it provides similar tensile strength, induces intracellular
growth and neovascularization, does not need to be
removed when used on contaminated surface during
reconstruction, and is 50% less expensive than the same
sized AlloDerm .8 Additionally, Permacol has an
advantage of easier manipulation. AlloDerm is divided
into dermis and basement membrane, and intracellular
growth and neovascularization occurs better in the
dermis. Therefore, when using AlloDerm for implant
breast reconstruction, smooth, shiny, well-blood absorp-
tive dermal surface has to face the subcutaneous tissue
side, while the opposite basement membrane side needs
to face the tissue expanders. Permacol , on the other
hand, can be easily transplanted without discriminating
sides and orientation.
As for this reason, this study aimed at comparing the
use of safe, cost-competitive, and easily manipulative
Permacol in tissue expander-implant breast reconstruc-
tion with the original AlloDerm sling operation. Both
the AlloDerm group and Permacol group achieved
natural looking lower-pole fullness and symmetric
inframammary fold, but the rate of complication varied
between the two groups. The rate of complications in
the AlloDerm group including infection (7%), hematoma
(3.7%), seroma (3.7%), and implant exposure (3.7%) cor-
responded with outcomes documented from previous
studies. Complications that occurred in the Permacol
group were infecton (36%), seroma (9%), and implant
exposure (9%), disclosing higher infection rate.
In investigation for the reason for such higher infection
rate, precedent studies were considered. Melman et al.
published a study comparing AlloDerm and Permacol
in porcine hernia model. Both materials maintained
similar tensile strength regardless of transplantation
period of 1~12 months, but biopsy results after 1 month
of transplantation revealed statistically significant result
of more neovascularization and intracellular prolifera-
tion in AlloDerm than Permacol , whereas there were
no significant difference between the two groups after
12 months.12 This outcome indicates that neovasculariza-
tion and intracellular proliferation occurs more slowly
in cross-linked three dimensionally structured Permacol
than non cross-linked AlloDerm . It has also been
confirmed in this study that endothelial cell proliferation
was present only in AlloDerm in histological analysis
of the samples acquired on the 7th postoperative day.
In this study, only one surface of Permacol was in
contact with the tissue since it encloses the tissue
expander, allowing only that surface available for
neovascularization and intracellular proliferation. This
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was the same case for AlloDerm , but it was less affected
by the reduced surface area as the dermis which is more
advantageous in angiogenesis and intracellular growth
faces the tissue. As reflected in Melman’s study, there
is a possibility that Permacol with slower rate of
neovascularization and intracellular proliferation will
take even longer with reduced surface contact in
comparison to transplantation into the abdominal wall.10
In addition, the skin flap in contact with Permacol is
usually given tension and the subcutaneous layer is often
damaged by continuous traction during mastectomy,
further delaying the process. It can be assumed that such
factors may have lead to increased rate of postoperative
infection in the Permacol group. However, the small
number of cases and relatively short follow-up period
has limitations in drawing conclusions that Permacol
increased infection rate.
Nonetheless, given that there are only a few reports
on the use of Permacol in breast reconstruction yet many
Korean surgeons in local clinics are using Permacol to
provide support for the soft tissue defect after breast
augmentation, and considering the cost-effectiveness and
lack of complications such as translocation or exposure
of implants and capsular contracture, Permacol will
prove efficacious in plastic surgery of the breasts with
the support of more future studies.
V. CONCLUSION
This study revealed that tissue expander-implant
breast reconstruction using Permacol is cost-effective,
yet holds higher risk of infection in comparison to
AlloDerm . But limitation of this study is a small number
of cases. Nevertherless, study on Permacol is only at
its beginning stage at the moment, requiring more cases
and studies to affirm its already established efficacy in
breast reconstructive surgery.
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